Armeli Federica, Mengoni Beatrice, Laskin Debra L, Businaro Rita
Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica, 79, 04100 Latina, Italy.
Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.
Curr Issues Mol Biol. 2024 Jul 2;46(7):6868-6884. doi: 10.3390/cimb46070410.
The onset of neurodegenerative diseases involves a complex interplay of pathological mechanisms, including protein aggregation, oxidative stress, and impaired autophagy. This review focuses on the intricate connection between oxidative stress and autophagy in neurodegenerative disorders, highlighting autophagy as pivotal in disease pathogenesis. Reactive oxygen species (ROS) play dual roles in cellular homeostasis and autophagy regulation, with disruptions of redox signaling contributing to neurodegeneration. The activation of the Nrf2 pathway represents a critical antioxidant mechanism, while autophagy maintains cellular homeostasis by degrading altered cell components. The interaction among p62/SQSTM1, Nrf2, and Keap1 forms a regulatory pathway essential for cellular stress response, whose dysregulation leads to impaired autophagy and aggregate accumulation. Targeting the Nrf2-p62/SQSTM1 pathway holds promise for therapeutic intervention, mitigating oxidative stress and preserving cellular functions. Additionally, this review explores the potential synergy between the endocannabinoid system and Nrf2 signaling for neuroprotection. Further research is needed to elucidate the involved molecular mechanisms and develop effective therapeutic strategies against neurodegeneration.
神经退行性疾病的发病涉及多种病理机制的复杂相互作用,包括蛋白质聚集、氧化应激和自噬受损。本综述聚焦于神经退行性疾病中氧化应激与自噬之间的复杂联系,强调自噬在疾病发病机制中起关键作用。活性氧(ROS)在细胞内稳态和自噬调节中发挥双重作用,氧化还原信号的破坏会导致神经退行性变。Nrf2途径的激活是一种关键的抗氧化机制,而自噬通过降解改变的细胞成分维持细胞内稳态。p62/SQSTM1、Nrf2和Keap1之间的相互作用形成了细胞应激反应所必需的调节途径,其失调会导致自噬受损和聚集体积累。靶向Nrf2-p62/SQSTM1途径有望用于治疗干预,减轻氧化应激并保护细胞功能。此外,本综述探讨了内源性大麻素系统与Nrf2信号传导之间潜在的协同作用对神经保护的影响。需要进一步研究以阐明其中涉及的分子机制,并开发针对神经退行性变的有效治疗策略。